PerpEquities

Zoetis Inc. (ZTS)财务

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · 员工14,500人 · CEO Kristin C. Peck

股价
$82.11 -7.95%
市值
$339亿
企业价值
$328亿
最近财报
Q3 '26 2026-11-05提交
下次财报
2027-02-11 EPS预期 $1.29
营收(TTM)$95.1亿+1.2% 对比去年同期最近4个季度;柱状图=各季度
营业利润率(TTM)37.0%-0.6 百分点 对比去年同期营业利润 $35.2亿
净利润(TTM)$24.9亿-6.2% 对比去年同期税后,含营业外收益
自由现金流(TTM)$22.8亿+1.7% 对比去年同期资本支出 $4.95亿
稀释EPS(TTM)$5.88-1.0% 对比去年同期最近4个季度之和
净现金$13.5亿+125.9% 对比去年同期现金 + 短期投资 - 债务

估值与关键数据

市值
$339亿
EV $328亿
营收
$95.1亿
过去12个月
营收增速
-2%
FY2026年一致预期
净利润率
26.1%
净利润 / 营收,TTM
P/E
13.9×
预期 13.2×(FY2026)
P/S
3.6×
股价 / 营收,TTM
EV / EBITDA
8.5×
TTM
自由现金流
$22.8亿
过去12个月
净利润
$24.9亿
过去12个月
营收预期
$92.7亿
FY2026年一致预期
盈利
2027-02-11
营收预期 $22.3亿
股息
$2.12
每股,过去12个月

核心要点

根据披露数据计算,每条结论都附有其依据的数字。

  • 最近财报(2026-11-05):营收超预期3.8%,EPS 超预期15.9%营收$23.9亿,预期$23亿(+3.8%);EPS $1.75,预期$1.51(+15.9%)。
  • 营收增长放缓:同比-0.4%Q3 '26营收$23.9亿,此前四个季度的平均值为1.4%。
  • 营业利润率37.0%(TTM),较去年同期-0.6 百分点营收增长1.2%,营业利润增长-0.4%。
  • 税前利润的13.1%被营业外亏损吞噬税前利润$31.1亿,营业利润$35.2亿(TTM)。股权投资亏损等一次性项目压低了净利润和EPS,营业利润更能反映业务本身。
  • 资本支出占营收的5.2%(去年为7.2%)最近4个季度投入$4.95亿(同比-26.8%)。自由现金流$22.8亿,相当于净利润的91.6%。
  • 股东回报$44.2亿 = 自由现金流的193.9%回购$37.5亿(去年为$17.3亿),股息$6.67亿,股权激励$1亿(TTM)。 超过自由现金流:由现金储备或举债支付。
  • 稀释股数一年内减少7.1%Q3 '26稀释股数4.12亿,一年前为4.43亿。
  • 净现金 $13.5亿现金 + 短期投资 $15.3亿,含租赁债务 $1.88亿;一年前净债务 $51.9亿。

上一季度:Q3 '26

截至2026-09-30的季度。与去年同期及财报发布前的分析师一致预期对比。

本季度与去年同期

Q3 '26去年同期变化
营收$23.9亿$24亿-0.4%
毛利率70.8%70.2%+0.6 百分点
营业利润$9.37亿$9.36亿+0.1%
营业利润率39.2%39.0%+0.2 百分点
净利润$5.91亿$7.21亿-18.0%
稀释EPS$1.44$1.63-11.7%
经营现金流$8.24亿$9.38亿-12.2%
资本支出$1.07亿$1.33亿-19.5%
自由现金流$7.17亿$8.05亿-10.9%
R&D$1.74亿$1.7亿+2.4%
股权激励费用$2700万$2200万+22.7%

实际 vs 一致预期

2026-11-05
实际一致预期对比预期
营收$23.9亿$23亿+3.8%
EPS(一致预期口径)$1.75$1.51+15.9%

来自2026-11-05发布的Q3 '26财报:营收及分析师预期口径的EPS(通常为调整后),可能与上方报表中的EPS不同。

EPS与一致预期

最近8次财报

营收

收入从何而来,按业务线和地区逐季展示。

营收、营业利润与增速

季度

按业务线划分的营收

堆叠,季度
分部Q3 '26同比占比TTMTTM同比12个季度
Horses$7300万+10.6%3.1%$63亿+5.0%
Dogs and Cats$14.9亿-5.9%64.0%$45.7亿+727.7%
Cattle$4.39亿+10.0%18.8%$16.4亿+10.8%
Swine$1.2亿+8.1%5.2%$4.85亿+3.4%
Poultry$1.08亿+1.9%4.6%$4.58亿+6.0%
Fish$9800万+25.6%4.2%$3.28亿+21.5%

按地区划分的营收

占总额比例
分部Q3 '26同比占比TTMTTM同比12个季度
United States Segment$12.5亿-5.7%52.8%$48.4亿-5.5%
International Segment$11.2亿+5.8%47.2%$45.6亿+9.3%

利润率与成本结构

每一单位营收在各层级还剩多少,成本又花在哪里。

利润率

季度

成本占营收比例

季度

现金流与资本配置

创造了多少现金,用在何处,又有多少回到股东手中。

经营现金流、资本支出、自由现金流

季度

现金用途与经营现金流

财年

最近4个季度

现金流量表
经营现金流
$27.7亿
资本支出
-$4.95亿
股票回购
-$37.5亿
股息
-$6.67亿
收购
-$1.69亿
债务净发行
$17.8亿
股权激励费用
$1亿
自由现金流
$22.8亿
股东回报 / FCF
193.9%

股数与EPS

季度,稀释

资产负债表

各季度末的流动性、投资和债务。

现金、投资与债务

季度末

估值与回报

当前估值倍数与公司自身过去五个财年对比;分析师目标价与评级。

估值倍数与回报

TTM与过去5个财年
当前5年均值当前处于5年区间的位置
P/E(TTM)13.9×35.8×20.9× – 56.9×
EV / EBITDA8.5×24.2×15.5× – 37.5×
EV / 营收3.4×10.1×6.7× – 15.3×
股价 / FCF14.9×46.3×24.4× – 66.7×
股价 / 净资产10.2×18.3×15.5× – 25.5×
FCF收益率6.7%2.5%1.5% – 4.1%
投入资本回报率22.7%20.0%17.8% – 22.2%
净资产收益率76.4%54.4%44.8% – 80.2%

分析师

一致目标价 $84.75 (+3.2%)
区间 $74.00 – $95.00 · 评级 Hold

强烈买入1
买入13
持有18
卖出0
强烈卖出0

展望

分析师对未来财年的一致预期,以及按当前股价意味着什么。

一致预期

财年营收增速EPS增速按当前股价的P/E分析师(EPS)
FY2026$92.7亿-2.1%$6.21+3.2%13.2×10
FY2027$93.4亿+0.8%$6.34+2.0%13.0×10
FY2028$96.7亿+3.6%$6.76+6.8%12.1×7
FY2029$102亿+5.0%$7.93+17.3%10.4×2
FY2030$106亿+4.7%$8.75+10.3%9.4×4

财务报表

利润表、资产负债表和现金流量表的每一项,含12个季度和10个财年,以金额、占营收比例或增速展示。

全部披露项目

Zoetis Inc.在近期10-Q / 10-K文件中标记的全部347项数据,附SEC官方标签和定义,包括附注(租赁、税务、回购、员工等)。

项目(SEC标签)最近季度去年同期同比最近财年上一财年同比
Accounts Payable, Current$4.19亿$4.1亿+2.2%$4.87亿$4.33亿+12.5%
Accounts Receivable, after Allowance for Credit Loss, Current$16.9亿$15.4亿+9.8%$15.9亿$13.2亿+20.8%
Accounts Receivable, Allowance for Credit Loss, Current$1400万$1800万-22.2%$1600万$1800万-11.1%
Accrued Income Taxes, Noncurrent$2.95亿$2.7亿+9.3%$2.76亿$2.72亿+1.5%
Accrued Liabilities, Current$8.52亿2025-12-31$7.46亿+14.2%$8.52亿$7.46亿+14.2%
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment$31.4亿$28.7亿+9.2%$29.3亿$26.4亿+11.0%
Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax$400万2025-12-31$200万+100.0%$400万$200万+100.0%
Accumulated Other Comprehensive Income (Loss), Net of Tax-$7.55亿-$8.18亿+7.7%-$8.34亿-$9.4亿+11.3%
Additional Paid in Capital$11.6亿$12.2亿-5.6%$11亿$11.8亿-6.9%
AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium–––-$1.45亿––
Advertising Expense–––$3.08亿$3.02亿+2.0%
Amortization of Intangible Assets$3900万$3900万0.0%$1.57亿$1.7亿-7.6%
APIC, Share-based Payment Arrangement, Increase for Cost Recognition$2600万$2200万+18.2%$7300万$6500万+12.3%
Asset Impairment Charges$9300万$900万+933.3%$4700万$3100万+51.6%
Asset Retirement Obligations, Noncurrent$2500万2025-12-31$2300万+8.7%$2500万$2300万+8.7%
Assets$151亿$152亿-0.5%$155亿$142亿+8.6%
Assets, Current$62.9亿$65.8亿-4.4%$67.7亿$59.9亿+13.1%
Buildings and Improvements, Gross$15.5亿2025-12-31$12.9亿+19.9%$15.5亿$12.9亿+19.9%
Business Exit Costs$100万$500万-80.0%$700万$0–
Capital Expenditures Incurred but Not yet Paid$0$0–$400万$300万+33.3%
Capitalized Computer Software, Amortization–––$4600万$6100万-24.6%
Capitalized Computer Software, Net$1800万2025-12-31$1800万0.0%$1800万$1800万0.0%
Cash and Cash Equivalents, at Carrying Value$13.3亿$20.8亿-36.0%$15.6亿2017-12-31$7.27亿+115.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents$13.3亿$22.7亿-41.3%$23.1亿$19.9亿+16.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect-$1.43亿$6.38亿-122.4%$3.25亿-$5400万+701.9%
Commercial Paper$0$0–$0$0–
Common Stock, Dividends, Per Share, Cash Paid–––$2.03$1.80+13.0%
Common Stock, Dividends, Per Share, Declared$0.00$0.00––––
Common Stock, Par or Stated Value Per Share$0.01$0.010.0%$0.01$0.010.0%
Common Stock, Shares Authorized60亿60亿0.0%60亿60亿0.0%
Common Stock, Shares, Issued5.02亿5.02亿0.0%5.02亿5.02亿0.0%
Common Stock, Shares, Outstanding4.07亿4.41亿-7.7%4.25亿4.48亿-5.3%
Common Stock, Value, Issued$500万$500万0.0%$500万$500万0.0%
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest$0$0–$0$1000万-100.0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent$6.32亿$7.43亿-14.9%$27.8亿$23.9亿+16.5%
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest$6.32亿$7.43亿-14.9%$27.8亿$24亿+16.0%
Construction in Progress, Gross$13亿2025-12-31$13.5亿-4.3%$13亿$13.5亿-4.3%
Contract with Customer, Liability$1800万$1800万0.0%$1700万$1800万-5.6%
Contract with Customer, Liability, Revenue Recognized$100万$600万-83.3%$1100万$400万+175.0%
Cost of Goods and Services Sold$6.98亿$6.97亿+0.1%$26.7亿$27.2亿-1.9%
Current Federal Tax Expense (Benefit)–––$2.23亿$6.45亿-65.4%
Current Foreign Tax Expense (Benefit)–––$3.27亿$2.65亿+23.4%
Current State and Local Tax Expense (Benefit)–––$5600万$6500万-13.8%
Debt Instrument, Unamortized Discount (Premium), Net-$8100万-$6400万-26.6%$9300万$5400万+72.2%
Deferred Federal Income Tax Expense (Benefit)–––$1.16亿-$2.97亿+139.1%
Deferred Foreign Income Tax Expense (Benefit)–––-$4900万$100万-5,000.0%
Deferred Income Tax Assets, Net$6.08亿$5.87亿+3.6%$6.37亿$5.4亿+18.0%
Deferred Income Tax Expense (Benefit)-$1200万-$1600万+25.0%-$5200万-$3.38亿+84.6%
Deferred Income Tax Liabilities, Net$1.04亿$1.47亿-29.3%$1.39亿$1.67亿-16.8%
Deferred State and Local Income Tax Expense (Benefit)–––$1400万-$4200万+133.3%
Deferred Tax Asset, Interest Carryforward$1200万2025-12-31$300万+300.0%$1200万$300万+300.0%
Deferred Tax Assets, Derivative Instruments$5600万2025-12-31$0–$5600万$0–
Deferred Tax Assets, Hedging Transactions$4200万2025-12-31$0–$4200万$0–
Deferred Tax Assets, in Process Research and Development$4.1亿2025-12-31$3.01亿+36.2%$4.1亿$3.01亿+36.2%
Deferred Tax Assets, Inventory$2400万2025-12-31$2100万+14.3%$2400万$2100万+14.3%
Deferred Tax Assets, Net$4.98亿2025-12-31$3.73亿+33.5%$4.98亿$3.73亿+33.5%
Deferred Tax Assets, Net of Valuation Allowance$6.08亿$5.87亿+3.6%–––
Deferred Tax Assets, Operating Loss Carryforwards$1.65亿2025-12-31$1.39亿+18.7%$1.65亿$1.39亿+18.7%
Deferred Tax Assets, Other$700万2025-12-31$0–$700万$0–
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits$7300万2025-12-31$7400万-1.4%$7300万$7400万-1.4%

来源:SEC companyfacts(每份10-Q / 10-K的XBRL)。现金流量表的季度数据由10-Q标记的年初至今累计数推算。分部拆分带有维度标记,在分部章节中单独展示。

数据来源

报表、分部营收、指标和预期均根据公司文件标准化。分部利润及全部披露项目:SEC EDGAR(XBRL)。 已读取的文件: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30

数据截至 2026-11-06